SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-14-032623
Filing Date
2014-02-03
Accepted
2014-02-03 13:46:05
Documents
3
Effectiveness Date
2014-02-03

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d668486d8k.htm DEFA14A 20498
2 EX-99.1 d668486dex991.htm EX-99.1 8460
3 GRAPHIC g668486image1.jpg GRAPHIC 6399
  Complete submission text file 0001193125-14-032623.txt   38934
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-12465 | Film No.: 14567524
SIC: 2834 Pharmaceutical Preparations